Helus Pharma Inc. SEC filings HELP

Helus Pharma Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 20, 2020. Its latest annual report, Form 40-F, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on March 31.

Helus Pharma Inc. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 3, 2026 Nov 3, 2026
3 Initial insider ownership Nov 2, 2026 Oct 16, 2026
6-K Current report (foreign issuer) Oct 27, 2026 Oct 27, 2026
3 Initial insider ownership Oct 26, 2026 Oct 13, 2026
3 Initial insider ownership Oct 26, 2026 Oct 13, 2026
3 Initial insider ownership Oct 23, 2026 Oct 13, 2026
3 Initial insider ownership Oct 23, 2026 Oct 13, 2026
3 Initial insider ownership Oct 23, 2026 Oct 13, 2026
3 Initial insider ownership Oct 23, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Oct 21, 2026 Oct 21, 2026
6-K Current report (foreign issuer) Oct 15, 2026 Oct 15, 2026
6-K Current report (foreign issuer) Oct 8, 2026 Oct 8, 2026
6-K Current report (foreign issuer) Oct 5, 2026 Oct 1, 2026
6-K Current report (foreign issuer) Oct 2, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
4 Insider transaction Oct 1, 2026 Sep 29, 2026
3 Initial insider ownership Oct 1, 2026 Sep 29, 2026
4 Insider transaction Oct 1, 2026 Sep 30, 2026
6-K Current report (foreign issuer) Oct 1, 2026 Oct 1, 2026
6-K Current report (foreign issuer) Sep 23, 2026 Sep 22, 2026
6-K Current report (foreign issuer) Sep 22, 2026 Sep 21, 2026
4 Insider transaction Sep 21, 2026 Sep 21, 2026
6-K Current report (foreign issuer) Sep 21, 2026 Sep 21, 2026
3 Initial insider ownership Sep 17, 2026 Sep 17, 2026
4 Insider transaction Sep 11, 2026 Sep 8, 2026
4 Insider transaction Sep 11, 2026 Sep 8, 2026
4 Insider transaction Sep 11, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Sep 10, 2026 Sep 10, 2026
4 Insider transaction Sep 10, 2026 Sep 4, 2026
4 Insider transaction Sep 10, 2026 Sep 3, 2026
SCHEDULE 13D Ownership over 5% (active) Sep 9, 2026 —
4 Insider transaction Sep 9, 2026 Sep 1, 2026
3 Initial insider ownership Sep 9, 2026 Sep 1, 2026
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
SCHEDULE 13D Ownership over 5% (active) Sep 9, 2026 —
4 Insider transaction Sep 9, 2026 Aug 31, 2026
3 Initial insider ownership Sep 9, 2026 Aug 31, 2026
6-K Current report (foreign issuer) Sep 3, 2026 Sep 3, 2026
S-8 Employee stock plan registration Sep 1, 2026 —
D Filing Sep 1, 2026 —
D Filing Aug 19, 2026 —
D Filing Aug 19, 2026 —
6-K Current report (foreign issuer) Aug 19, 2026 Aug 18, 2026
6-K Current report (foreign issuer) Aug 18, 2026 Aug 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
6-K Current report (foreign issuer) Aug 14, 2026 Aug 14, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 12, 2026 —
6-K Current report (foreign issuer) Aug 11, 2026 Aug 10, 2026
6-K Current report (foreign issuer) Aug 3, 2026 Aug 3, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jul 21, 2026
6-K Current report (foreign issuer) Jul 16, 2026 Jun 26, 2026
D Filing Jul 16, 2026 —
D Filing Jul 16, 2026 —
6-K Current report (foreign issuer) Jun 29, 2026 Jun 29, 2026
40-F Annual report (Canadian issuer) Jun 29, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Jun 25, 2026 Jun 25, 2026
6-K Current report (foreign issuer) Jun 25, 2026 Jun 23, 2026
SUPPL Form suppl Jun 25, 2026 —
FWP Free writing prospectus Jun 24, 2026 —
6-K Current report (foreign issuer) Jun 11, 2026 Jun 11, 2026
6-K Current report (foreign issuer) Jun 1, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
6-K Current report (foreign issuer) May 4, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Apr 30, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Apr 28, 2026 Apr 28, 2026
6-K Current report (foreign issuer) Apr 23, 2026 Apr 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 22, 2026 —
6-K Current report (foreign issuer) Apr 20, 2026 Apr 20, 2026
6-K Current report (foreign issuer) Apr 20, 2026 Apr 20, 2026
6-K Current report (foreign issuer) Apr 16, 2026 Apr 16, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 26, 2026 —
D Filing Mar 23, 2026 —
6-K Current report (foreign issuer) Mar 12, 2026 Mar 12, 2026
6-K Current report (foreign issuer) Mar 5, 2026 Mar 5, 2026
6-K Current report (foreign issuer) Mar 5, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Feb 24, 2026 Feb 24, 2026
6-K Current report (foreign issuer) Feb 18, 2026 Feb 18, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
6-K Current report (foreign issuer) Feb 17, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
6-K Current report (foreign issuer) Feb 13, 2026 Feb 13, 2026
6-K Current report (foreign issuer) Feb 10, 2026 Feb 10, 2026
D Filing Jan 12, 2026 —
6-K Current report (foreign issuer) Jan 5, 2026 Jan 5, 2026
CERT Filing Jan 2, 2026 —
8-A12B Form 8-a12b Jan 2, 2026 —
25 Notification of removal from listing Jan 2, 2026 —
6-K Current report (foreign issuer) Dec 31, 2025 Dec 31, 2025
6-K Current report (foreign issuer) Dec 30, 2025 Dec 30, 2025
SUPPL Form suppl Dec 30, 2025 —
6-K Current report (foreign issuer) Dec 22, 2025 Dec 18, 2025
F-X Form f-x Dec 19, 2025 —
F-10 Form f-10 Dec 19, 2025 —
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
6-K Current report (foreign issuer) Nov 26, 2025 Nov 26, 2025
D Filing Nov 26, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
6-K Current report (foreign issuer) Nov 13, 2025 Nov 13, 2025
6-K Current report (foreign issuer) Nov 12, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 7, 2025 —
6-K Current report (foreign issuer) Nov 6, 2025 Nov 6, 2025
6-K Current report (foreign issuer) Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 4, 2025 —
6-K Current report (foreign issuer) Nov 3, 2025 Nov 3, 2025
6-K Current report (foreign issuer) Oct 31, 2025 Oct 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 29, 2025 —
6-K Current report (foreign issuer) Oct 29, 2025 Oct 27, 2025
SUPPL Form suppl Oct 29, 2025 —
FWP Free writing prospectus Oct 28, 2025 —
FWP Free writing prospectus Oct 28, 2025 —
6-K Current report (foreign issuer) Oct 28, 2025 Oct 28, 2025
FWP Free writing prospectus Oct 28, 2025 —
D Filing Oct 15, 2025 —
6-K Current report (foreign issuer) Sep 23, 2025 Sep 23, 2025
D Filing Sep 23, 2025 —
6-K Current report (foreign issuer) Sep 18, 2025 Sep 17, 2025
SUPPL Form suppl Sep 18, 2025 —
SUPPL Form suppl Sep 18, 2025 —
SUPPL Form suppl Sep 17, 2025 —
SUPPL Form suppl Sep 17, 2025 —
F-10/A Form f-10/a Sep 17, 2025 —
6-K Current report (foreign issuer) Sep 17, 2025 Sep 3, 2025
6-K Current report (foreign issuer) Sep 11, 2025 Sep 11, 2025
6-K Current report (foreign issuer) Sep 9, 2025 Sep 8, 2025
6-K Current report (foreign issuer) Sep 4, 2025 Sep 4, 2025
6-K Current report (foreign issuer) Sep 3, 2025 Sep 3, 2025
6-K Current report (foreign issuer) Sep 2, 2025 Sep 2, 2025
D Filing Aug 27, 2025 —
D Filing Aug 27, 2025 —
6-K Current report (foreign issuer) Aug 26, 2025 Aug 26, 2025
6-K Current report (foreign issuer) Aug 19, 2025 Aug 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
6-K Current report (foreign issuer) Aug 14, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Aug 13, 2025 Aug 12, 2025
6-K Current report (foreign issuer) Aug 7, 2025 Aug 7, 2025
6-K Current report (foreign issuer) Aug 6, 2025 Aug 6, 2025
F-X Form f-x Jul 31, 2025 —
F-10 Form f-10 Jul 31, 2025 —
6-K Current report (foreign issuer) Jul 28, 2025 Jul 28, 2025
6-K Current report (foreign issuer) Jul 17, 2025 Jul 17, 2025
6-K Current report (foreign issuer) Jul 14, 2025 Jul 14, 2025
SUPPL Form suppl Jul 14, 2025 —
D Filing Jul 10, 2025 —
6-K Current report (foreign issuer) Jul 10, 2025 Jul 10, 2025
6-K Current report (foreign issuer) Jul 1, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jul 1, 2025 Jun 30, 2025
40-F Annual report (Canadian issuer) Jul 1, 2025 Mar 31, 2025
6-K Current report (foreign issuer) Jun 13, 2025 Jun 13, 2025
6-K Current report (foreign issuer) Jun 12, 2025 Jun 12, 2025
6-K Current report (foreign issuer) Jun 11, 2025 Jun 11, 2025
6-K Current report (foreign issuer) Jun 3, 2025 Jun 3, 2025
6-K Current report (foreign issuer) May 22, 2025 May 22, 2025
SCHEDULE 13G Ownership over 5% (passive) May 21, 2025 —
6-K Current report (foreign issuer) May 20, 2025 May 20, 2025
6-K Current report (foreign issuer) May 15, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
6-K Current report (foreign issuer) May 14, 2025 May 14, 2025
6-K Current report (foreign issuer) May 8, 2025 May 8, 2025
6-K Current report (foreign issuer) May 1, 2025 May 1, 2025
6-K Current report (foreign issuer) Apr 23, 2025 Apr 23, 2025
6-K Current report (foreign issuer) Apr 21, 2025 Apr 21, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
6-K Current report (foreign issuer) Feb 14, 2025 Feb 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
6-K Current report (foreign issuer) Feb 11, 2025 Feb 10, 2025
SUPPL Form suppl Feb 11, 2025 —
6-K Current report (foreign issuer) Feb 11, 2025 Feb 10, 2025
6-K Current report (foreign issuer) Jan 15, 2025 Jan 15, 2025
EFFECT Filing Jan 14, 2025 —
6-K Current report (foreign issuer) Jan 13, 2025 Jan 13, 2025
6-K Current report (foreign issuer) Jan 10, 2025 Jan 9, 2025
F-X Form f-x Jan 8, 2025 —
F-10 Form f-10 Jan 8, 2025 —
6-K Current report (foreign issuer) Dec 10, 2024 Dec 10, 2024
D Filing Dec 10, 2024 —
6-K Current report (foreign issuer) Dec 4, 2024 Dec 4, 2024
SC 13G Ownership over 5% (passive) Dec 3, 2024 —
6-K Current report (foreign issuer) Nov 18, 2024 Nov 18, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
6-K Current report (foreign issuer) Nov 14, 2024 Nov 14, 2024
6-K Current report (foreign issuer) Nov 13, 2024 Nov 13, 2024
6-K Current report (foreign issuer) Nov 1, 2024 Nov 1, 2024
6-K Current report (foreign issuer) Oct 24, 2024 Oct 24, 2024
6-K Current report (foreign issuer) Oct 3, 2024 Oct 3, 2024
6-K Current report (foreign issuer) Oct 1, 2024 Oct 1, 2024
6-K Current report (foreign issuer) Sep 24, 2024 Sep 24, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 19, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 19, 2024
D Filing Sep 9, 2024 —
6-K Current report (foreign issuer) Sep 4, 2024 Sep 4, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Aug 29, 2024
6-K Current report (foreign issuer) Aug 28, 2024 Aug 27, 2024
SC 13G Ownership over 5% (passive) Aug 27, 2024 —
6-K/A Filing Aug 19, 2024 Aug 16, 2024
6-K Current report (foreign issuer) Aug 15, 2024 Aug 15, 2024
6-K Current report (foreign issuer) Aug 13, 2024 Aug 13, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HELP (Nasdaq)
Fiscal year ends
March 31
Incorporated in
British Columbia, Canada
Headquarters
Toronto
SEC filer status
, Emerging growth company
SEC CIK
1833141
Former names
CYBIN INC. (until Sep 23, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.